Mesalamine for the treatment of cancer
AssigneeCipla Limited
InventorsGeena Malhotra, Kalpana Joshi, Jeevan Ghosalkar
Life of this patent
Estimating the term…
Abstract
Methods of treating renal cancer, including renal cell carcinoma, using mesalamine are disclosed herein. Mesalamine can be administered as a monotherapy or as part of a comprehensive treatment program, which can also include administration with other anti-cancer drugs, surgical treatments or exposure to ionizing radiation.
Claims17
A method for the treatment of renal cell carcinoma in a patient, the method comprising administering to said patient mesalamine, or a pharmaceutically acceptable salt or prodrug thereof, in an amount effective to treat renal cell carcinoma.
A pharmaceutical composition comprising mesalamine and at least one additional renal cell carcinoma therapeutic agent.
A kit comprising mesalamine and at least one additional renal cell carcinoma therapeutic agent.
Dependencies are inferred from the claim text.